ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0

CUSIP: 464337AG9

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Debt / NOTE 2.750%10/0
Market price (% of par)
300.0%
Total 13F principal
$5,000
Principal change
$0
Total reported market value
$15,000
Number of holders
1

Quarterly Holders Quick Answers

What is CUSIP 464337AG9?
CUSIP 464337AG9 identifies 464337AG9 - ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 as of Q2 2017

As of 30 Jun 2017, ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 was held by 1 institutional bondholder reporting positions in Form 13F filings. These institutions reported holding $5,000 in principal (par value) of the bond. The largest 1 bondholders included BANK OF AMERICA CORP /DE/. This page lists 1 institutional bondholders reporting positions for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.